| Amedisys Home Health Of Pa | |
| 1368 Mall Run Road, Suite 628, Uniontown, Pennsylvania 15401 | |
| (724) 438-6660 | |
| Name | Amedisys Home Health Of Pa |
|---|---|
| Location | 1368 Mall Run Road, Suite 628, Uniontown, Pennsylvania |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 397139 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 15004, 15012, 15017, 15019, 15020, 15021, 15022, 15025, 15026, 15033, 15034, 15037, 15045, 15046, 15047, 15053, 15054, 15055, 15057, 15060, 15062, 15063, 15067, 15071, 15072, 15078, 15083, 15085, 15087, 15088, 15089, 15102, 15106, 15108, 15110, 15112, 15120, 15122, 15126, 15129, 15131, 15132, 15133, 15135, 15136, 15137, 15142, 15145, 15146, 15148, 15201, 15203, 15204, 15205, 15206, 15207, 15208, 15210, 15211, 15213, 15216, 15217, 15218, 15219, 15220, 15221, 15222, 15224, 15225, 15226, 15227, 15228, 15232, 15233, 15234, 15235, 15236, 15239, 15241, 15243, 15301, 15310, 15311, 15312, 15313, 15314, 15315, 15316, 15317, 15320, 15321, 15322, 15323, 15324, 15325, 15327, 15329, 15330, 15331, 15332, 15333, 15334, 15336, 15337, 15338, 15339, 15340, 15341, 15342, 15344, 15345, 15346, 15347, 15348, 15349, 15350, 15351, 15352, 15357, 15358, 15359, 15360, 15361, 15362, 15363, 15364, 15366, 15367, 15368, 15370, 15376, 15377, 15379, 15380, 15401, 15410, 15411, 15412, 15413, 15415, 15416, 15417, 15419, 15420, 15421, 15422, 15423, 15424, 15425, 15427, 15428, 15429, 15430, 15431, 15432, 15433, 15434, 15435, 15436, 15437, 15438, 15440, 15442, 15443, 15444, 15445, 15446, 15447, 15449, 15450, 15451, 15455, 15456, 15458, 15459, 15460, 15461, 15462, 15463, 15464, 15465, 15466, 15467, 15468, 15469, 15470, 15472, 15473, 15474, 15475, 15476, 15477, 15478, 15479, 15480, 15482, 15483, 15484, 15486, 15488, 15489, 15492, 15601, 15610, 15611, 15612, 15620, 15622, 15623, 15624, 15626, 15627, 15628, 15631, 15632, 15634, 15636, 15637, 15638, 15639, 15642, 15644, 15650, 15658, 15660, 15663, 15666, 15668, 15670, 15672, 15675, 15677, 15678, 15679, 15681, 15683, 15684, 15685, 15687, 15688, 15692, 15697, 15698, 15717, 15923 |
| NPI Number | 1598719379 |
| Organization Name | ALBERT GALLATIN HOME CARE AND HOSPICE SERVICES, LLC |
| Doing Business As | AMEDISYS HOME HEALTH OF PA |
| Address | 1368 Mall Run Rd, Suite 628, Uniontown, PA 15401 |
| Phone Number | 724-438-6660 |
News Archive
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.
Scientists earlier found that mice missing one of a group of core developmental genes known as the Hox genes developed an odd and rather unexpected pathology: the mutant animals groomed themselves compulsively to the point that they were removing their own hair and leaving self-inflicted open sores on their skin. Now, they've found a surprising connection between the Hoxb8 gene and the behavior that looks an awful lot like that of people with an obsessive compulsive spectrum disorder (OCD).
Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.
Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published on January in Annals of Allergy, Asthma & Immunology, the scientific journal of the American Collegeof Allergy, Asthma and Immunology.
Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.
› Verified 9 days ago
| Quality Rating: |
News Archive
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.
Scientists earlier found that mice missing one of a group of core developmental genes known as the Hox genes developed an odd and rather unexpected pathology: the mutant animals groomed themselves compulsively to the point that they were removing their own hair and leaving self-inflicted open sores on their skin. Now, they've found a surprising connection between the Hoxb8 gene and the behavior that looks an awful lot like that of people with an obsessive compulsive spectrum disorder (OCD).
Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.
Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published on January in Annals of Allergy, Asthma & Immunology, the scientific journal of the American Collegeof Allergy, Asthma and Immunology.
Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.6 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
| How often the home health team checked patients for depression | 93.8 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 80.9 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 81.9 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.7 | 96.4 |
News Archive
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.
Scientists earlier found that mice missing one of a group of core developmental genes known as the Hox genes developed an odd and rather unexpected pathology: the mutant animals groomed themselves compulsively to the point that they were removing their own hair and leaving self-inflicted open sores on their skin. Now, they've found a surprising connection between the Hoxb8 gene and the behavior that looks an awful lot like that of people with an obsessive compulsive spectrum disorder (OCD).
Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.
Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published on January in Annals of Allergy, Asthma & Immunology, the scientific journal of the American Collegeof Allergy, Asthma and Immunology.
Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 87.4 | 79.6 |
| How often patients got better at getting in and out of bed | 88.1 | 81.1 |
| How often patients got better at bathing | 88.9 | 82.3 |
| How often patients’ breathing improved | 90.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 95.6 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 79.6 | 75 |
| How often home health patients had to be admitted to the hospital | 16.6 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.7 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99 | 94 |
News Archive
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.
Scientists earlier found that mice missing one of a group of core developmental genes known as the Hox genes developed an odd and rather unexpected pathology: the mutant animals groomed themselves compulsively to the point that they were removing their own hair and leaving self-inflicted open sores on their skin. Now, they've found a surprising connection between the Hoxb8 gene and the behavior that looks an awful lot like that of people with an obsessive compulsive spectrum disorder (OCD).
Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.
Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published on January in Annals of Allergy, Asthma & Immunology, the scientific journal of the American Collegeof Allergy, Asthma and Immunology.
Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.
› Verified 9 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.
Scientists earlier found that mice missing one of a group of core developmental genes known as the Hox genes developed an odd and rather unexpected pathology: the mutant animals groomed themselves compulsively to the point that they were removing their own hair and leaving self-inflicted open sores on their skin. Now, they've found a surprising connection between the Hoxb8 gene and the behavior that looks an awful lot like that of people with an obsessive compulsive spectrum disorder (OCD).
Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.
Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published on January in Annals of Allergy, Asthma & Immunology, the scientific journal of the American Collegeof Allergy, Asthma and Immunology.
Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.
› Verified 9 days ago
The patient survey data of Amedisys Home Health Of Pa is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 89 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 84 | 78 |
News Archive
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.
Scientists earlier found that mice missing one of a group of core developmental genes known as the Hox genes developed an odd and rather unexpected pathology: the mutant animals groomed themselves compulsively to the point that they were removing their own hair and leaving self-inflicted open sores on their skin. Now, they've found a surprising connection between the Hoxb8 gene and the behavior that looks an awful lot like that of people with an obsessive compulsive spectrum disorder (OCD).
Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.
Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published on January in Annals of Allergy, Asthma & Immunology, the scientific journal of the American Collegeof Allergy, Asthma and Immunology.
Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.
› Verified 9 days ago
Amedisys Home Health Of Pa Location: 1368 Mall Run Road, Suite 628, Uniontown, Pennsylvania 15401 Ratings: Phone: (724) 438-6660 | |
Abby Health Care Inc Location: 287 Edison Street, Uniontown, Pennsylvania 15401 Ratings: Phone: (724) 439-2229 |